Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$1.04 - $322.5 $7.88 Million - $2.44 Billion
7,575,758 New
7,575,758 $13 Million
Q3 2021

Nov 15, 2021

BUY
$1.44 - $2.73 $10.9 Million - $20.7 Million
7,575,758 New
7,575,758 $13.8 Million

Others Institutions Holding TCRT

About Alaunos Therapeutics, Inc.


  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $458M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Msd Partners, L.P. Portfolio

Follow Msd Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Msd Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Msd Partners, L.P. with notifications on news.